ResearchThe Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement
ResearchOutcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry
ResearchManagement of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic
ResearchGuidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19
ResearchLongitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies
ResearchInfants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
ResearchYes, We Are Still Talking about Cyclosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis
ResearchRecommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
ResearchA Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business
ResearchChange in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC
ResearchAnti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease